Analytical Characterization 2014

The second track of the Biotherapeutics Analytical Summit on Analytical Characterization of Biotherapeutics presents advances in analytical technologies using a range of products as examples including antibody-drug conjugates and bi-specifics. There is a focus on the characterization of particulates, host cell proteins and sequence variants, including an FDA presentation on particle characterization and product release limits. Additional sessions cover analysis of variants and the relationship between structure and function.